GILD
$GILD
Gilead Sciences, Inc.
Biopharmaceutical company focused on HIV, hepatitis, and oncology.
HealthcareSubscribers
1
Tracking this ticker
Latest Report
Analysis from Sep 26, 2026
GILD: Oncology Pivot and Mixed Fundamentals
Gilead ($GILD) trades near analyst mean targets after strong multi-year returns. Positive momentum from oncology and HIV franchises is offset by GAAP earnings weakness and limited yield, leaving a neutral stance.
Sep 27, 2026